Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.

• Status: Completed
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Evaluation of use of low dose tadalafil 5 mg daily for treatment of female OAB syndrome

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kasr El Aini Hospital
• Treatments: Tadalafil; Tolterodine Tartrate

Criteria

Inclusion Criteria:

• any female with overactive bladder syndrome, urgency with or without urgency urinary incontinence

Exclusion Criteria:

• Active Urinary tract infection

• neurologic abnormality

• Pure Stress urinary incontinence